Integrating Metabolomics and Machine Learning Reveals Metabolic Signatures and Candidate Biomarkers for Vestibular Migraine.

This research focuses on vestibular migraine (VM), a condition causing vertigo and headaches. VM is common but often goes unrecognized, and its metabolic features are not well understood. Researchers studied the blood of 33 people with VM and 30 healthy individuals. They also analyzed another group of 37 VM patients and 27 healthy controls. They found 510 metabolites that were different between the two groups. Out of these, 197 were more abundant in VM patients, while 313 were less abundant. The study used machine learning to identify three promising metabolites: phenylethylamine, N-acetylserotonin, and cysteine-S-sulfate. These metabolites could help in diagnosing VM, as they showed strong predictive capability. This research highlights the potential for using blood markers to better understand and diagnose vestibular migraine, which may lead to improved patient care and management in the future. Clinical relevance: This study suggests that specific metabolites may serve as biomarkers for diagnosing vestibular migraine, potentially leading to better treatment strategies for patients experiencing this condition.